Precipio
Precipio Receives CE-IVD Mark for Hematologic Cancer Panels
The company said it can now market its HemeScreen MPN, AML, Anemia/MDS, and CLL panels in the European Union and the UK.
Former Precipio CFO, Son Agree to Settle SEC Insider Trading Lawsuit
Former Precipio CFO Carl Iberger was charged with providing confidential information regarding a company distribution deal for a COVID-19 test.
In Brief This Week: Myriad Genetics, Precipio, LumiraDx, Guardant Health, and More
News items for the in vitro diagnostics industry for the week of Jan. 18, 2021.
Precipio to Effect 1-for-15 Reverse Stock Split
The cancer diagnostics developer said it was undertaking the reverse stock split in order to meet the Nasdaq's $1 minimum bid price requirement.
Mar 13, 2018
Precipio Settles Lawsuit With Investment Group
Feb 27, 2018
Precipio Sued Over Transgenomic Securities Agreement
Nov 13, 2017
Precipio Completes Public Offering, Raises $2.7M
Apr 17, 2017
Transgenomic Closes Bridge Financing
Jan 12, 2017